Effecacy of anti-platelet drugs after endovascular therapy in patients with femoropopliteal artery disease

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2009
INTERVENTION: sarpogrelate 100mgx3/day, 24weeks cilostazol 100mgx3/day, 24weeks CONDITION: peripheral artery disease PRIMARY OUTCOME: percent diameter stenosis of the target lesion on angiography INCLUSION CRITERIA: Patients with successful endovascular therapy for femoropopliteal artery disease (lesional pressure gradient less than 20mmHg or residual percent diameter stenosis less than 50%)
Epistemonikos ID: b89ec729d5f40f8a3157821ce1a492837aa06bc2
First added on: Aug 22, 2024